ATP2A2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.313200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.155900E-02
Normal-vs-Stage2
2.616000E-01
Normal-vs-Stage3
8.711800E-01
Normal-vs-Stage4
1.160810E-01
Stage1-vs-Stage2
2.179000E-01
Stage1-vs-Stage3
8.599700E-02
Stage1-vs-Stage4
6.616200E-01
Stage2-vs-Stage3
2.771200E-01
Stage2-vs-Stage4
5.672800E-01
Stage3-vs-Stage4
1.734250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.260200E-01
Normal-vs-AfricanAmerican
2.731200E-01
Normal-vs-Asian
5.995600E-01
Caucasian-vs-AfricanAmerican
7.701600E-01
Caucasian-vs-Asian
1.563180E-01
AfricanAmerican-vs-Asian
2.377600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.202400E-01
Normal-vs-Female
2.410400E-01
Male-vs-Female
1.710430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.860800E-01
Normal-vs-Age(41-60Yrs)
9.807800E-02
Normal-vs-Age(61-80Yrs)
3.377400E-01
Normal-vs-Age(81-100Yrs)
3.040400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.881600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.948400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.963400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.002900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.185050E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.624200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.283800E-01
Normal-vs-Daily Drinker
2.772000E-01
Normal-vs-Weekly Drinker
3.085000E-01
Normal-vs-Occasional Drinker
1.733170E-01
Normal-vs-Social Drinker
1.744650E-01
Non Drinker-vs-Daily Drinker
2.040200E-01
Non Drinker-vs-Weekly Drinker
2.704400E-01
Non Drinker-vs-Occasional Drinker
2.477500E-02
Non Drinker-vs-Social Drinker
5.387800E-02
Daily Drinker-vs-Weekly Drinker
9.967200E-01
Daily Drinker-vs-Occasional Drinker
1.458610E-01
Daily Drinker-vs-Social Drinker
4.629600E-01
Weekly Drinker-vs-Occasional Drinker
2.179400E-01
Weekly Drinker-vs-Social Drinker
5.166200E-01
Occasional Drinker-vs-Social Drinker
4.774400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.072360E-01
Normal-vs-Grade 2
5.451600E-02
Normal-vs-Grade 3
2.392000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.871800E-01
Grade 1-vs-Grade 3
4.449200E-01
Grade 1-vs-Grade 4
1.072360E-01
Grade 2-vs-Grade 3
8.972400E-01
Grade 2-vs-Grade 4
5.451600E-02
Grade 3-vs-Grade 4
2.392000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.951800E-01
Normal-vs-NonDiabetic
2.549000E-01
Diabetic-vs-NonDiabetic
3.543800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.936200E-01
Normal-vs-NoPancreatitis
2.745600E-01
Pancreatitis-vs-NoPancreatitis
5.946000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.096000E-01
Normal-vs-N1
2.698600E-01
N0-vs-N1
6.072800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.664600E-01
Normal-vs-TP53-NonMutant
2.294600E-01
TP53-Mutant-vs-TP53-NonMutant
7.054200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
